BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16179285)

  • 1. Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
    Haberbosch W; Gardemann A
    Scand J Clin Lab Invest; 2005; 65(6):513-22. PubMed ID: 16179285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
    Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
    Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease.
    Gardemann A; Lohre J; Katz N; Tillmanns H; Hehrlein FW; Haberbosch W
    Thromb Haemost; 1999 Sep; 82(3):1121-6. PubMed ID: 10494775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis.
    Wang J; Warzecha D; Wilcken D; Wang XL
    Clin Sci (Lond); 2001 Jul; 101(1):87-92. PubMed ID: 11410119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.
    Duman BS; Türkoğlu C; Akpinar B; Güden M; Vertii A; Cağatay P; Günay D; Sevim Büyükdevrim A
    Ann Hum Biol; 2005; 32(5):620-9. PubMed ID: 16316917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
    Keavney B; Danesh J; Parish S; Palmer A; Clark S; Youngman L; Delépine M; Lathrop M; Peto R; Collins R
    Int J Epidemiol; 2006 Aug; 35(4):935-43. PubMed ID: 16870675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention.
    Cho HJ; Chae IH; Park KW; Ju JR; Oh S; Lee MM; Park YB
    J Hum Genet; 2002; 47(2):88-91. PubMed ID: 11916008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases.
    Rechciński T; Grebowska A; Kurpesa M; Peruga Z; Dziuba M; Krzemińska-Pakuła M; Rudnicka W; Chmiela M
    Kardiol Pol; 2007 Mar; 65(3):237-44; discussion 245. PubMed ID: 17436151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese.
    Jiao GQ; Yuan ZX; Xue YS; Yang CJ; Lu CB; Lu ZQ; Xiao MD
    Clin Biochem; 2007 Oct; 40(15):1108-12. PubMed ID: 17674965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction.
    Seckin D; Ilhan N; Ilhan N; Ozbay Y
    Clin Biochem; 2006 Jan; 39(1):50-4. PubMed ID: 16303122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease.
    Sentinelli F; Filippi E; Fallarino M; Romeo S; Fanelli M; Buzzetti R; Berni A; Baroni MG
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):345-52. PubMed ID: 16829343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.
    Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD
    J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease].
    Gao B; Li ZC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):536-9. PubMed ID: 15355616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of polymorphisms in the 5'-flanking region of the apolipoprotein(a) [Apo(a)] gene in Thai subjects with coronary artery diseases.
    Tirawanchai N; Leowattana W; Somkasetrin A; Thongsaen P
    J Med Assoc Thai; 2008 Jan; 91(1):86-92. PubMed ID: 18386550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery disease and a functional polymorphism of hTERT.
    Matsubara Y; Murata M; Watanabe K; Saito I; Miyaki K; Omae K; Ishikawa M; Matsushita K; Iwanaga S; Ogawa S; Ikeda Y
    Biochem Biophys Res Commun; 2006 Sep; 348(2):669-72. PubMed ID: 16890917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial infarction in patients aged less than 40 years. Frequency of BclI polymorphism in the fibrinogen beta-chain gene and plasma fibrinogen.
    Lewandowski K; Kwaśnikowski P; Elikowski W; Zawilska K
    Kardiol Pol; 2003 Sep; 59(9):205-12. PubMed ID: 14618197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction.
    Nauck M; Winkelmann BR; Hoffmann MM; Böhm BO; Wieland H; März W
    J Mol Med (Berl); 2002 Aug; 80(8):507-13. PubMed ID: 12185451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.